2,283
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Gastric lesions in patients with autoimmune metaplastic atrophic gastritis: a retrospective study in a single center

, , , , &
Pages 1296-1303 | Received 05 Apr 2022, Accepted 18 May 2022, Published online: 29 May 2022

References

  • Rustgi SD, Bijlani P, Shah SC. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Therap Adv Gastroenterol. 2021;14:17562848211038771.
  • Hu HY, Zhang Q, Chen GY, et al. Risk factors and clinical correlates of neoplastic transformation in gastric hyperplastic polyps in chinese patients. Sci Rep. 2020;10(1):2582.
  • Magris R, Re VD, Maiero S, et al. Low pepsinogen I/II ratio and high gastrin-17 levels typify chronic atrophic autoimmune gastritis patients with gastric neuroendocrine tumors. Clin Transl Gastroenterol. 2020;11(9):e00238.
  • Mahmud N, Stashek K, Katona BW, et al. The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance. Ann Gastroenterol. 2019;32(1):67–72.
  • Kamada T, Maruyama Y, Monobe Y, et al. Endoscopic features and clinical importance of autoimmune gastritis. Dig Endosc. 2022;34(4):700–713.
  • Kato M. Endoscopic features of early-stage autoimmune gastritis. Intern Med. 2020;59(23):2969–2970.
  • Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32(3):364–372.
  • The paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach and Colon: November 30 to december 1,2002. Gastrointest Endosc. 2003;58:S3–S43.
  • Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
  • Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–541.
  • Massironi S, Zilli A, Elvevi A, et al. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215–222.
  • Pittman ME, Voltaggio L, Bhaijee F, et al. Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation. Am J Surg Pathol. 2015;39(12):1611–1620.
  • Arai J, Niikura R, Hayakawa Y, et al. Clinicopathological features of gastric cancer with autoimmune gastritis. Biomedicines. 2022;10(4):884.
  • Toyoshima O, Nishizawa T, Koike K. Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis. World J Gastroenterol. 2020;26(5):466–477.
  • Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1(03):87–97.
  • Kotelevets SM, Chekh SA, Chukov SZ. Updated Kimura-Takemoto classification of atrophic gastritis. World J Clin Cases. 2021;9(13):3014–3023.
  • Tatsuta M, Iishi H, Nakaizumi A, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer. 1993;53(1):70–74.
  • Shichijo S, Hirata Y, Sakitani K, et al. Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol. 2015;30(8):1260–1264.
  • Brenner H, Arndt V, Stegmaier C, et al. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol. 2004;159(3):252–258.
  • Ekström AM, Held M, Hansson LE, et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001;121(4):784–791.
  • Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44(5):693–697.
  • Tong YL, Wang HG, Zhao Y, et al. Diagnostic value of serum pepsinogen levels for screening gastric cancer and atrophic gastritis in asymptomatic individuals: a cross-sectional study. Front Oncol. 2021;11:652574.
  • Choudhuri J, Hall S, Castrodad-Rodriguez CA, et al. Features that aid identification of autoimmune gastritis in a background of active helicobacter pylori infection. Arch Pathol Lab Med. 2021;145(12):1536–1543.
  • Furuta T, Baba S, Yamade M, et al. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther. 2018;48(3):370–377.